Advertisement
Screener

Aditxt, Inc. (ADTX) Form D

Aditxt, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-01-23: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2023-12-29; Total offering amount $6,000,000.
  • 2023-09-20: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2023-09-06; Total offering amount $10,000,000.
  • 2022-08-17: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2022-08-04; Total offering amount $2,200,000.
  • 2021-01-26: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Senior Secured Convertible Promissory Note; Date of first sale 2021-01-25; Total offering amount $6,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-01-23Rule 506(b)Equity; SecurityToBeAcquired2023-12-29$6,000,000$6,000,000$01
2023-09-20Rule 506(b)Equity; OptionToAcquire2023-09-06$10,000,000$10,000,000$01
2022-08-17Rule 506(b)Equity; Debt; OptionToAcquire; SecurityToBeAcquired2022-08-04$2,200,000$2,033,333$166,6676
2021-01-26Rule 506(b)Debt; OptionToAcquire; SecurityToBeAcquired; Senior Secured Convertible Promissory Note2021-01-25$6,000,000$6,000,000$01
2018-12-26Rule 506(c)Equity; OptionToAcquire; SecurityToBeAcquired2018-11-27$2,000,000$109,800$1,890,2004
2018-03-29Rule 506(c)Equity; SecurityToBeAcquired2018-03-17$2,000,000$262,500$1,737,5008

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rafael Holdings, Inc. (RFL)United States$0.000B-0.00
CDT Equity Inc. (CDT)United States$0.000B-0.01
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B